Will the Oxford/AstraZeneca bubonic plague vaccine be approved in the UK by end of 2025? | Binary | | | 6 days ago | |
CDC revises Hepatitis B vaccine recommendation for pregnancy by end of 2024? | Binary | | | 1 month ago | |
Will the UK government stockpile the new bubonic plague vaccine by end of 2025? | Binary | | | 6 days ago | |
Dato-DXd receives FDA approval for lung cancer by end of 2025? | Binary | | | 18 days ago | |
First company to get ADC approved for lung cancer in EU by end of 2025? | Categorical | | | 18 days ago | |
AstraZeneca/Daiichi Sankyo reapply for EU approval of Dato-DXd by end of 2025? | Binary | | | 18 days ago | |
AstraZeneca faces more lawsuits on vaccine safety for pregnancy by mid-2025? | Binary | | | 1 month ago | |
Legal outcome of AstraZeneca vaccine compensation case by end of 2025? | Categorical | | | 1 month ago | |
Significant drop in Tagrisso sales due to RYBREVANT and LAZCLUZE by end of 2025? | Binary | | | 4 days ago | |
Market leader in lung cancer treatments by end of 2025? | Categorical | | | 4 days ago | |
Standard of care for lung cancer by end of 2025? | Categorical | | | 4 days ago | |
Highest revenue growth in oncology treatments by end of 2025? | Categorical | | | 4 days ago | |
FDA approval for RYBREVANT and LAZCLUZE as first-line lung cancer treatment by end of 2025? | Binary | | | 4 days ago | |
RYBREVANT and LAZCLUZE capture over 50% lung cancer treatment market share by end of 2025? | Binary | | | 4 days ago | |
Which country will first approve the Oxford/AstraZeneca bubonic plague vaccine by end of 2025? | Categorical | | | 6 days ago | |
How many doses of the bubonic plague vaccine will Oxford/AstraZeneca produce by end of 2025? | Categorical | | | 6 days ago | |
Which major company will first partner with Oxford/AstraZeneca for bubonic plague vaccine distribution by end of 2025? | Categorical | | | 6 days ago | |
Will the new bubonic plague vaccine be used in a UK public health campaign by end of 2025? | Binary | | | 6 days ago | |
New phase III trial for Dato-DXd in lung cancer announced by mid-2025? | Binary | | | 18 days ago | |
Next EU regulatory action for Dato-DXd by end of 2025? | Categorical | | | 18 days ago | |
Outcome of next major clinical trial for Dato-DXd by end of 2025? | Categorical | | | 18 days ago | |
First health organization to revise vaccine guidelines for pregnancy by mid-2025? | Categorical | | | 1 month ago | |
Outcome of vaccine safety concerns for pregnancy by end of 2024? | Categorical | | | 1 month ago | |
New study on AstraZeneca vaccine safety for pregnancy published by end of 2025? | Binary | | | 1 month ago | |